owner,pais,producto,searchStrategy,scope,searchUrl,searchDate,articles_number
ELEA,Argentina,NOVEX,rituximab or novex,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28rituximab+or+novex%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-02,38
ELEA,Argentina,NOVEX,rituximab or novex,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28rituximab+or+novex%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-09,0
ELEA,Argentina,NOVEX,rituximab or novex,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28rituximab+or+novex%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-16,0
ELEA,Argentina,NOVEX,rituximab or novex,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28rituximab+or+novex%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-23,0
ELEA,Argentina,BEVAX,bevacizumab OR bevax,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28(bevacizumab)+OR+(bevax)%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-02,29
ELEA,Argentina,BEVAX,bevacizumab OR bevax,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28(bevacizumab)+OR+(bevax)%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-09,0
ELEA,Argentina,BEVAX,bevacizumab OR bevax,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28(bevacizumab)+OR+(bevax)%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-16,0
ELEA,Argentina,BEVAX,bevacizumab OR bevax,internacional,https://pesquisa.bvsalud.org/portal/?output=site&lang=es&from=0&sort=&format=summary&count=100&fb=&page=1&skfp=&index=&q=%28(bevacizumab)+OR+(bevax)%29+AND+%28%28da%3A%28%22202409%22%29%29+OR+%28da%3A%28%22202408%22%29%29+OR+%28da%3A%28%22202400%22%29%29%29&search_form_submit=,2024-09-23,0
